首页> 外文期刊>Dhaka University Journal of Pharmaceutical Sciences >Study on the Development of Diltiazem HCl Loaded Colonic Drug Delivery Systems (CDDS) Using Various Polymers and Characterization of their Release Profiles by In Vitro Dissolution Studies
【24h】

Study on the Development of Diltiazem HCl Loaded Colonic Drug Delivery Systems (CDDS) Using Various Polymers and Characterization of their Release Profiles by In Vitro Dissolution Studies

机译:使用多种聚合物开发盐酸地尔硫卓的结肠给药系统(CDDS)的开发及其通过体外溶出研究表征释放曲线的研究

获取原文
       

摘要

This investigation describes the preparation and in vitro evaluation of Colonic Drug Delivery of Diltiazem HCl tablet. Methocel K 4M premium, Methocel K 100M premium CR, Methocel K 15M CR and Xanthan gum were used for release controlling properties. For this purpose, tablets containing 90 mg of Diltiazem HCl along with different amounts of the aforementioned polymers were prepared using direct compression technique. All the formulations were then evaluated for thickness, hardness, diameter, weight variation and in vitro drug release characteristics as per USP monograph. Tablets prepared were placed in a basket type dissolution apparatus containing HCl solution (pH-1.2) for the first 2 hours and phosphate buffer (pH-7.4) for the next 6 hours of the study. The amount of drug released was determined at 237nm by a UV-visible spectrophotometer. Fitting of release data to different kinetic models showed that Methocel K 4M premium containing matrices conformed based to Korsmeyer release kinetics, Methocel K 100M CR based matrices to Korsmeyer and zero order, Methocel K 15M CR based matrices to zero order kinetics and Xanthan gum containing tablets to either of Higuchi and Korsmeyer release kinetics. The release exponent (n) derived from Korsmeyer-Peppas equation for the studied formulations implied that the release of Diltiazem HCl from Methocel K 4M premium based matrices and Methocel K 100M CR based formulations was Super case II transport mechanism. The value of release exponent (n) for Methocel K 15M CR containing matrices was mainly governed by Super case II transport. Xanthan gum based formulations was Anomalous/ Non-Fickian. Briefly, Methocel K 15M CR was found to be suitable for sustaining the release of Diltiazem HCl from matrix formulation inside the colon. Key words: Colonic Drug Delivery; Direct Compression; Methocel K 4M premium; Methocel K 100M CR; Methocel K 15M CR; Xanthan gum. DOI: 10.3329/dujps.v9i1.7424 Dhaka Univ. J. Pharm. Sci. 9(1): 7-13, 2010 (June)
机译:这项研究描述了盐酸地尔硫卓片的结肠给药的制备和体外评价。 Methocel K 4M premium,Methocel K 100M premium CR,Methocel K 15M CR和黄原胶用于控制释放性能。为此,使用直接压片技术制备含有90mg盐酸地尔硫卓以及不同量的上述聚合物的片剂。然后根据USP专论评估所有制剂的厚度,硬度,直径,重量变化和体外药物释放特性。将制备的片剂置于篮子型溶出度仪中,在开始的前2小时放入装有HCl溶液(pH-1.2),在随后的6小时放入装有磷酸盐缓冲液(pH-7.4)的篮子中。用紫外可见分光光度计在237nm处测定释放的药物量。释放数据与不同动力学模型的拟合结果表明,含Methocel K 4M premium的基质符合Korsmeyer释放动力学,基于Methocel K 100M CR的基质符合Korsmeyer和零阶,基于Methocel K 15M CR的基质具有零阶动力学和含黄原胶的片剂对Higuchi和Korsmeyer的释放动力学。从Korsmeyer-Peppas方程得出的释放指数(n)表示所研究制剂的盐酸地尔硫卓从Methocel K 4M优质基质和Methocel K 100M CR的制剂中释放是Super case II转运机制。含有Methocel K 15M CR的基质的释放指数(n)的值主要由Super case II转运决定。黄原胶基配方是反常/非菲克安式的。简而言之,发现Methocel K 15M CR适用于维持结肠内基质制剂中盐酸地尔硫卓的释​​放。关键词:结肠给药直接压缩; Methocel K 4M Premium; Methocel K 100M CR; Methocel K 15M CR;黄原胶。 DOI:10.3329 / dujps.v9i1.7424达卡大学。 J.药物科学9(1):7-13,2010(6月)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号